{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:39:35Z","timestamp":1791319175471,"version":"4.3.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite continued efforts to improve the safety of catheter ablation, pericardial tamponade remains one of its more frequent, potentially life-threatening complications. Management of cardiac tamponade is not standardized and uncertainties regarding acute treatment remain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This survey sought to evaluate the management of cardiac tamponade in German EP centers via a standardized postal questionnaire. All 341 identified German EP centers were invited to return a questionnaire on their standards for the management of cardiac tamponade.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 189 German EP centers completed the questionnaire. Several precautions are followed to avoid pericardial tamponade: A minority of centers preclude very old patients (19%) or those with a high body mass index (30%) from ablation. Non-vitamin K antagonist oral anticoagulants are briefly paused in most centers (88%) before procedures, while vitamin K antagonists are continued. Pericardial tamponade is usually treated using reversal of heparin by applying\u00a0protamine (86%) and pericardiocentesis under both, fluoroscopic and echocardiographic guidance (62%). A pigtail catheter is mostly inserted (97%) and autotransfusion of aspirated blood is performed in 47% of centers. The decision for surgical repair depends on different clinical and infrastructural aspects. The timing of reinitiation of anticoagulation widely differs between the centers. Approximately 1\/3 of centers prescribe nonsteroidal anti-inflammatory agents, colchicine or steroids after pericardiocentesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The present survey shows that the management of cardiac tamponade is still inhomogeneous in German ablation centers. However, multiple findings of this survey can be generalized and might guide especially less experienced operators and centers in their treatment and decision strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00392-022-02042-x","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:26:24Z","timestamp":1655465184000},"page":"1727-1737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of pericardial tamponade in the electrophysiology laboratory: results from a national survey"],"prefix":"10.1007","volume":"112","author":[{"given":"Andreas","family":"Metzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan D.","family":"Reubold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sch\u00f6nhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Rei\u00dfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rottner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Schleberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Dinshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"M\u00fcnkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinwan","family":"Kany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Steven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3457-0936","authenticated-orcid":false,"given":"Andreas","family":"Rillig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"2042_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373\u2013498","journal-title":"Eur Heart J"},{"key":"2042_CR2","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/europace\/euz132","volume":"21","author":"EM Cronin","year":"2019","unstructured":"Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N et al (2019) 2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 21:1143\u20131144","journal-title":"Europace"},{"key":"2042_CR3","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.jacc.2019.08.1036","volume":"74","author":"EP Cheng","year":"2019","unstructured":"Cheng EP, Liu CF, Yeo I, Markowitz SM, Thomas G, Ip JE et al (2019) Risk of mortality following catheter ablation of atrial fibrillation. J Am Coll Cardiol 74:2254\u20132264","journal-title":"J Am Coll Cardiol"},{"key":"2042_CR4","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.113.003862","volume":"128","author":"A Deshmukh","year":"2013","unstructured":"Deshmukh A, Patel NJ, Pant S, Shah N, Chothani A, Mehta K et al (2013) In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation 128:2104\u20132112","journal-title":"Circulation"},{"key":"2042_CR5","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/europace\/euaa080","volume":"22","author":"T Fink","year":"2020","unstructured":"Fink T, Sciacca V, Feickert S, Metzner A, Lin T, Schluter M et al (2020) Outcome of cardiac tamponades in interventional electrophysiology. Europace 22:1240\u20131251","journal-title":"Europace"},{"key":"2042_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/europace\/euy131","volume":"20","author":"A Bollmann","year":"2018","unstructured":"Bollmann A, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Sause A et al (2018) Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER). Europace 20:1944\u20131951","journal-title":"Europace"},{"key":"2042_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","volume":"3","author":"R Cappato","year":"2010","unstructured":"Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3:32\u201338","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2042_CR8","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s00392-019-01471-5","volume":"108","author":"T Fink","year":"2019","unstructured":"Fink T, Metzner A, Willems S, Eckardt L, Ince H, Brachmann J et al (2019) Procedural success, safety and patients satisfaction after second ablation of atrial fibrillation in the elderly: results from the German Ablation Registry. Clin Res Cardiol 108:1354\u20131363","journal-title":"Clin Res Cardiol"},{"key":"2042_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/europace\/eux128","volume":"20","author":"V Tscholl","year":"2018","unstructured":"Tscholl V, Lin T, Lsharaf AK, Bellmann B, Nagel P, Lenz K et al (2018) Cryoballoon ablation in the elderly: one year outcome and safety of the second-generation 28mm cryoballoon in patients over 75 years old. Europace 20:772\u2013777","journal-title":"Europace"},{"key":"2042_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijcard.2018.09.090","volume":"278","author":"CH Heeger","year":"2019","unstructured":"Heeger CH, Bellmann B, Fink T, Bohnen JE, Wissner E, Wohlmuth P et al (2019) Efficacy and safety of cryoballoon ablation in the elderly: a multicenter study. Int J Cardiol 278:108\u2013113","journal-title":"Int J Cardiol"},{"key":"2042_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/europace\/euv229","volume":"18","author":"I Metzner","year":"2016","unstructured":"Metzner I, Wissner E, Tilz RR, Rillig A, Mathew S, Schmidt B et al (2016) Ablation of atrial fibrillation in patients >\/=75 years: long-term clinical outcome and safety. Europace 18:543\u2013549","journal-title":"Europace"},{"key":"2042_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00399-020-00698-4","volume":"31","author":"L Rottner","year":"2020","unstructured":"Rottner L, Reissmann B, Schleberger R, Sinning C, Metzner A, Rillig A (2020) Management of acute complications during electrophysiological procedures. Herzschrittmacherther Elektrophysiol 31:381\u2013387","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"2042_CR13","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG et al (2021) 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 23:1612\u20131676","journal-title":"Europace"},{"key":"2042_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","volume":"376","author":"H Calkins","year":"2017","unstructured":"Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH et al (2017) Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med 376:1627\u20131636","journal-title":"N Engl J Med"},{"key":"2042_CR15","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","volume":"39","author":"P Kirchhof","year":"2018","unstructured":"Kirchhof P, Haeusler KG, Blank B, De Bono J, Callans D, Elvan A et al (2018) Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. Eur Heart J 39:2942\u20132955","journal-title":"Eur Heart J"},{"key":"2042_CR16","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1093\/eurheartj\/ehz190","volume":"40","author":"SH Hohnloser","year":"2019","unstructured":"Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbuchel H, Mont L et al (2019) Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial. Eur Heart J 40:3013\u20133021","journal-title":"Eur Heart J"},{"key":"2042_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jacep.2017.11.005","volume":"4","author":"MR Reynolds","year":"2018","unstructured":"Reynolds MR, Allison JS, Natale A, Weisberg IL, Ellenbogen KA, Richards M et al (2018) A prospective randomized trial of apixaban dosing during atrial fibrillation ablation: The AEIOU Trial. JACC Clin Electrophysiol 4:580\u2013588","journal-title":"JACC Clin Electrophysiol"},{"key":"2042_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/jce.14332","volume":"31","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Li L, Liu N, Zhang M, Wu K, Ruan Y et al (2020) Early versus delayed removal of the pericardial drain in patients with cardiac tamponade complicating radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 31:597\u2013603","journal-title":"J Cardiovasc Electrophysiol"}],"updated-by":[{"DOI":"10.1007\/s00392-022-02066-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000}}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02042-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02042-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02042-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T16:56:57Z","timestamp":1701795417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02042-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02042-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00392-022-02066-3","asserted-by":"object"}]},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00392-022-02066-3","URL":"https:\/\/doi.org\/10.1007\/s00392-022-02066-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Andreas Metzner has received speakers honoraria from Medtronic, Biosense Webster, Boston Scientific and Cardiofocus. Daniel Steven has received speakers honoraria from Abbott, Boston Scientific and Biosense Webster and he received research grants from Medtronic, Abbott and Biosense Webster. Philipp Sommer is Member of the Advisory Board for Abbott, Biosense Webster, Boston Scientific and Medtronic. PK was partially supported by European Union BigData@Heart (grant agreement EU IMI 116074), AFFECT-AF (grant agreement 847770), and MAESTRIA (grant agreement 965286), British Heart Foundation (PG\/17\/30\/32961; PG\/20\/22\/35093; AA\/18\/2\/34218), German Centre for Cardiovascular Research supported by the German Ministry of Education and Research (DZHK), and Leducq Foundation. Paulus Kirchhof receives research support for basic, translational, and clinical research projects from European Union, British Heart Foundation, Leducq Foundation, Medical Research Council (UK), and German Centre for Cardiovascular Research, from several drug and device companies active in atrial fibrillation, and has received honoraria from several such companies in the past, but not in the last three years. PK is listed as inventor on two patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783). Andreas Rillig received consultant fees from Medtronic, KODEX-EPD, Biosense Webster and travel grants and lecture fees from Medtronic, Cardiofocus, Biosense Webster, Abbott, Boehringer Ingelheim, Philips KODEX-EPD, Ablamap, Bayer and Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}